Related references
Note: Only part of the references are listed.Recombinant modified vaccinia virus Ankara-based malaria vaccines
Sarah Sebastian et al.
EXPERT REVIEW OF VACCINES (2016)
Deciphering Poxvirus Gene Expression by RNA Sequencing and Ribosome Profiling
Zhilong Yang et al.
JOURNAL OF VIROLOGY (2015)
Safety and immunogenicity of a modified-vaccinia-virus-Ankara-based influenza A H5N1 vaccine: a randomised, double-blind phase 1/2a clinical trial
Joost H. C. M. Kreijtz et al.
LANCET INFECTIOUS DISEASES (2014)
Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
Arwen F. Altenburg et al.
VIRUSES-BASEL (2014)
Gene Expression Driven by a Strong Viral Promoter in MVA Increases Vaccination Efficiency by Enhancing Antibody Responses and Unmasking CD8+ T Cell Epitopes
Pablo D. Becker et al.
VACCINES (2014)
Clinical applications of attenuated MVA poxvirus strain
Carmen Elena Gomez et al.
EXPERT REVIEW OF VACCINES (2013)
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
Asisa Volz et al.
VACCINE (2013)
Clinical development of Modified Vaccinia virus Ankara vaccines
Sarah C. Gilbert
VACCINE (2013)
Critical Role of Perforin-dependent CD8+T Cell Immunity for Rapid Protective Vaccination in a Murine Model for Human Smallpox
Melanie Kremer et al.
PLOS PATHOGENS (2012)
Interplay between Modified Vaccinia Virus Ankara and Dendritic Cells: Phenotypic and Functional Maturation of Bystander Dendritic Cells
Maria F. Pascutti et al.
JOURNAL OF VIROLOGY (2011)
Resistance of Akt kinases to dephosphorylation through ATP-dependent conformational plasticity
Tung O. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Memories that last forever: strategies for optimizing vaccine T-cell memory
Jeffrey D. Ahlers et al.
BLOOD (2010)
Preclinical Studies of a Modified Vaccinia Virus Ankara-Based HIV Candidate Vaccine: Antigen Presentation and Antiviral Effect
Samantha Brandler et al.
JOURNAL OF VIROLOGY (2010)
Modified Vaccinia Virus Ankara Exerts Potent Immune Modulatory Activities in a Murine Model
Miriam Noerder et al.
PLOS ONE (2010)
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes
Lorena E. Brown et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector Vaccines
Georg Gasteiger et al.
JOURNAL OF VIROLOGY (2007)
Colocalization of transcription and translation within cytoplasmic poxvirus factories coordinates viral expression and subjugates host functions
George C. Katsafanas et al.
CELL HOST & MICROBE (2007)
Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination
Wolfgang Kastenmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Infection of human dendritic cells with recombinant vaccinia virus MVA reveals general persistence of viral early transcription but distinct maturation-dependent cytopathogenicity
Wolfgang Kastenmuller et al.
VIROLOGY (2006)
Poxvirus CD8+ T-cell determinants and cross-reactivity in BALB/c mice
David C. Tscharke et al.
JOURNAL OF VIROLOGY (2006)
Identification and characterization of three immunodominant structural proteins of fowlpox virus
D Boulanger et al.
JOURNAL OF VIROLOGY (2002)
N-terminal N-myristoylation of proteins:: Refinement of the sequence motif and its taxon-specific differences
S Maurer-Stroh et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
Share Paper
